Deutsche Bank’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-25
| Closed | – | – | 5063 |
|
|
2018
Q3 | $0 | Buy |
+25
| New | – | ﹤0.01% | 5111 |
|
|
2016
Q2 | – | Sell |
-1,263
| Closed | -$22K | – | 4929 |
|
|
2016
Q1 | $22K | Sell |
1,263
-1,322
| -51% | -$23K | ﹤0.01% | 4312 |
|
|
2015
Q4 | $68K | Sell |
2,585
-6,835
| -73% | -$180K | ﹤0.01% | 4006 |
|
|
2015
Q3 | $428K | Sell |
9,420
-391
| -4% | -$17.8K | ﹤0.01% | 3366 |
|
|
2015
Q2 | $315K | Buy |
9,811
+1,796
| +22% | +$57.7K | ﹤0.01% | 3538 |
|
|
2015
Q1 | $254K | Buy |
8,015
+11
| +0.1% | +$349 | ﹤0.01% | 3543 |
|
|
2014
Q4 | $302K | Sell |
8,004
-2,178
| -21% | -$82.2K | ﹤0.01% | 3880 |
|
|
2014
Q3 | $268K | Buy |
10,182
+269
| +3% | +$7.08K | ﹤0.01% | 3746 |
|
|
2014
Q2 | $291K | Sell |
9,913
-3,604
| -27% | -$106K | ﹤0.01% | 3738 |
|
|
2014
Q1 | $499K | Buy |
13,517
+556
| +4% | +$20.5K | ﹤0.01% | 3335 |
|
|
2013
Q4 | $536K | Sell |
12,961
-6,026
| -32% | -$249K | ﹤0.01% | 3069 |
|
|
2013
Q3 | $1.01M | Buy |
18,987
+3,824
| +25% | +$202K | ﹤0.01% | 2968 |
|
|
2013
Q2 | $808K | Buy |
+15,163
| New | +$808K | ﹤0.01% | 2845 |
|